E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
RCKT holding history
Rocket Pharmaceuticals, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −17,751−100.0% | Sold out | Holders |
| Q1 2026 | 17,751 | $63.5K | <0.1% | – | No prior filing | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −14,567−100.0% | Sold out | Holders |
| Q1 2025 | 14,567 | $97.2K | <0.1% | +3,513+31.8% | Added | Holders |
| Q4 2024 | 11,054 | $138.9K | <0.1% | +11,054 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −15,549−100.0% | Sold out | Holders |
| Q1 2024 | 15,549 | $418.9K | <0.1% | +4,352+38.9% | Added | Holders |
| Q4 2023 | 11,197 | $335.6K | <0.1% | −1,215−9.8% | Reduced | Holders |
| Q3 2023 | 12,412 | $254.0K | <0.1% | −120−1.0% | Reduced | Holders |
| Q2 2023 | 12,532 | $249.0K | <0.1% | −4,469−26.3% | Reduced | Holders |
| Q1 2023 | 17,001 | $291.0K | <0.1% | +1,601+10.4% | Added | Holders |
| Q4 2022 | 15,400 | $301.0K | <0.1% | −178−1.1% | Reduced | Holders |
| Q3 2022 | 15,578 | $249.0K | <0.1% | +15,578 | New | Holders |